EGRIFTA WR begins here with a US FDA medicine identity.
Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.
EGRIFTA WR begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the United Kingdom. Verify the exact local records below.
Resolve the exact identity of EGRIFTA WR through Current EGRIFTA WR prescribing information from National Library of Medicine, DailyMed. Then search Search licensed medicine product information from Medicines and Healthcare products Regulatory Agency for the destination product record and Search the register from General Pharmaceutical Council for the seller, establishment, or supply route in United Kingdom. A match in one record does not replace the other two checks.
No. A page using the name EGRIFTA WR, local currency, a domestic delivery claim, or a familiar package image is only a lead. EGRIFTA WR is an FDA-approved US tesamorelin prescription product with an exact application, presentation, indication, label, and regulated supply chain. The European Egrifta marketing-authorisation application was withdrawn in 2012. Neither record authenticates research vials, compounded preparations, imported packages, or seller claims, and neither establishes current authorization or supply in another jurisdiction. For United Kingdom, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.
EGRIFTA WR begins here with a US FDA medicine identity. That does not prove the same product, presentation, approval, prescription status, or current availability in the United Kingdom. Verify the exact local records below.
Primary identity source: Current EGRIFTA WR prescribing information / National Library of Medicine, DailyMed ↗A credible result must keep these separate. The official links answer different questions and should be checked in sequence.
Current EGRIFTA WR prescribing information is maintained by National Library of Medicine, DailyMed. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Current EGRIFTA WR prescribing information ↗Search licensed medicine product information is maintained by Medicines and Healthcare products Regulatory Agency. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Search licensed medicine product information ↗Search the register is maintained by General Pharmaceutical Council. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.
Open Search the register ↗A website can look clinical without being a registered pharmacy. The GPhC register is the relevant check for Great Britain pharmacy premises and professionals.
The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.
Confirm pharmacy premises and professional details in the official GPhC register.
Do not treat a laboratory chemical listing as a substitute for a prescribed medicine.
Keep the seller, batch document, currency, VAT, delivery limit, and date checked together.
Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.